HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The tocolytic role of nifedipine in preventing preterm labour pain.

Abstract
This study was undertaken to evaluate the efficacy of oral nifedipine to reduce labour pain in patient with preterm labour, to complete the doses of steroids in lung maturity and in utero transfer to the Neonatal Intensive Care Unit (NICU) and to evaluate the maternal adverse effects and neonatal outcome. Diagnosed cases of preterm labour (between 24 to 34 weeks gestation) were randomly selected. Among them 50 patients were given oral nifedipine (n=50) and 50 patients were observed with no treatment (n=50). There were no statistically significant differences in age, race, parity, preterm delivery risk factor between the groups. At first the labour pain were observed through Continuous CTG in first hour, then intermittent CTG. The patient in the Nifedipine group can prolong the pregnancy time 36.0±3.2 wks than 30.6±3.1 wks in the control group (p<0.05) with reduced neonatal complications and admission to NICU. Oral nifedipine in patients with preterm labour pain as Tocolytic therapy has significantly prolonged pregnancy with lesser neonatal problems and fewer maternal adverse effects.
AuthorsI Bina, T Parveen, A Khanom, P A Shamsunnahar
JournalMymensingh medical journal : MMJ (Mymensingh Med J) Vol. 21 Issue 1 Pg. 139-44 (Jan 2012) ISSN: 1022-4742 [Print] Bangladesh
PMID22314470 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Tocolytic Agents
  • Nifedipine
Topics
  • Adult
  • Analgesia, Obstetrical
  • Female
  • Humans
  • Nifedipine (therapeutic use)
  • Obstetric Labor, Premature (prevention & control)
  • Pregnancy
  • Tocolytic Agents (therapeutic use)
  • Uterine Contraction (drug effects)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: